FDA 483 - Boothwyn Pharmacy LLC - September 08, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Boothwyn Pharmacy LLC in Kennett Square, PA, revealed significant deficiencies in the production of both sterile and non-sterile drug products. Observations included inadequate aseptic processing techniques, insufficient cleaning and disinfection procedures, and a lack of proper environmental controls and quality assurance for critical processes like media fills and water quality. These issues indicate a failure to maintain a state of control necessary for drug manufacturing.
ID · a6c261eb-5d4a-48ad-9170-e81ee4c42d39